Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

DEN 7203 Pharmacological Concepts > Pharmacogenetics > Flashcards

Pharmacogenetics Flashcards

Lecture 5

1
Q

Every year, more than 100,000 people in die in the US because they carry ____ genes that make medications either ineffective or deadly

A

Misspelled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In addition to drug-drug interactions, there are also ____ interactions

A

gene-drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Genetic differences in plasma proteins results in:

A

Differences in affinity and extent of drug binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetic differences in metabolic enzymes results in:

A

Differences in concentration of drug, active metabolites, toxic derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetic differences in membrane proteins results in:

A

Differences in absorption, distribution, excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Genetic differences in receptors results in:

A

Differences in abundance or sensitivity –> therapeutic vs adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

____ is the study of differences in drug response due to allelic variation in genes affecting drug efficacy, metabolism, toxicity (variable response due to individual genes)

A

Pharmacogenetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Every person carries ____ copies of every gene

A

Two (homozygous or heterozygous)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is pharmacogenomics?

A

Genomic approach to pharmacogenetics concerned with the assessment of common genetic variants in the aggregate for their impact on the outcome of drug therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

____ is involved with a variable response due to multiple loci across the genome (different alleles across many different genes affecting the response of a drug)

A

Pharmacogenomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Large single-variant effect caused by:

A

Pharmacogenetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Smaller effect with multiple variants caused by:

A

Pharmacogenomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What two types of genetic mutation events create all forms of variations?

A
  • Single nucleotide polymorphisms (substitute one nucleotide for another)
  • Insertion or deletion polymorphisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a polymorphism?

A

A genetic variation observed at a frequency of more than 1% in a population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a mutation?

A

Genetic variation in less than 1% in a population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or false: SNPs are rare in the human population

A

False - very common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Between any two people, there is an average of one SNP every ____ bases

A

1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Do most SNPs have a phenotypic effect?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Estimate that ____ SNPs in the genome (how many bases total in the genome?)

A

3.2 million; 3 billion total

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Only ____ of all human SNPs impact protein function (most in non-coding regions)

A

< 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is a missense mutation?

A

Mutated codon codes for a different amino acid (could be significant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is a nonsense mutation?

A

Mutated codon is a premature stop codon (usually serious)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Insertion/deletion (INDEL) polymorphisms are ____ and ____ distributed throughout the human genome

A

Quite common; widely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

INDEL that add or subtract amino acids may:

A

Have no effect, alter the activity or abolish all activity of the affected protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
LARGE deletions result in:
Complete loss of protein expression
26
Gene duplication results in:
Stably transmitted inherited genes that cause increased protein expression and activity
27
Every person has two copies of every gene that are inherited ____
Independently
28
CYP450 genotypes result in:
Various combinations of wild-type or decreased activity, inactive, or duplicated alleles
29
List the different CYP450 Phenotypes
- Poor metabolizer - Intermediate metabolizer - Extensive metabolizer - Ultrarapid metabolizer
30
Poor metabolizer - genotype
2 inactive alleles of CYP450
31
Intermediate metabolizer - genotypes?
- 2 decreased activity alleles - One active allele and one inactive - One decreased activity allele and one inactive (CYP450)
32
Extensive metabolizer - genotype
2 functional alleles (wild type)
33
Ultrarapid metabolizer - genotype
Gene duplication in the absence of inactive or decreased alleles
34
Describe the pharmacokinetic effects of a poor metabolizer (CYP450)
Drug enters toxic range and tapers off but remains in toxic range
35
Describe the pharmacokinetic effects of an intermediate metabolizer (CYP450)
Drug enters toxic range but tapers off into therapeutic range and doesn't go below that
36
Describe the pharmacokinetic effects of an extensive metabolizer (CYP450)
Drug concentration peaks at therapeutic range and tapers off below this range as it is being broken down
37
Describe the pharmacokinetic effects of an ultrarapid metabolizer (CYP450)
Drug enters therapeutic range but quickly decreases below therapeutic range
38
If a patient is an ultrarapid metabolizer, how do you modify their treatment?
May have to prescribe a higher dose due to much more CYP450 being available
39
List examples of gene-drug interactions
- CYP2D6 and Codeine - ALDH2 and Ethanol - CYP2D6 and Tamoxifen
40
What is codeine?
Analgesic (painkiller)
41
____ is a prodrug
Codeine (inactive compound that when metabolized becomes an active drug)
42
____ is critical for codeine's analgesic effect
CYP2D6-mediated bioactivation
43
What is codeine metabolized into?
Morphine
44
What is the difference in structure between codeine and morphine?
Methyl group removed to create morphine
45
Codeine is more ____ Morphine is more ____
Lipophilic; hydrophilic
46
A poor metabolizer (CYP2D6) of codeine would result in:
No analgesic effect of morphine (no metabolism = no activation of codeine)
47
An intermediate metabolizer (CYP2D6) of codeine would result in:
Slight analgesic effect of morphine
48
An extensive metabolizer (CYP2D6) of codeine would result in:
Effective pain relief from morphine
49
An ultra metabolizer (CYP2D6) of codeine would result in:
"overdose" effect
50
Low dose of ethanol causes:
- Muscle relaxant - Euphoria - Impaired judgment
51
High dose of ethanol causes:
- CNS depressant - Impaired sensory/motor function
52
When does ethanol become toxic?
When BAC > 400mg/dL (0.4%)
53
How does ethanol metabolism occur?
Two steps: - Alcohol dehydrogenase (ADH) converts ethanol to acetaldehyde - Aldehyde dehydrogenase (ALDH2) converts acetaldehyde to acetic acid (detoxification step)
54
____ is a toxic metabolite during ethanol metabolism
Acetaldehyde
55
ALDH2 has an alternative allele in which:
Lysine residue replaces a glutamate in the active site at position 487 of ADH2
56
ALDH2 alternative allele can result in what genotypes?
- ALDH2 *1/*1 wild type homozygous - ALDH2 *1/*2 Heterozygous - ALDH2 *2/*2 Variant homozygous
57
Homozygous individuals (ALDH2 *2/*2) with the variant allele have:
Almost no ALDH2 activity (8% of normal)
58
Heterozygous individuals (ALDH2 *1/*2) have:
Reduced activity
59
ALDH2 is a ____ (structure)
Tetramer
60
ALDH2 influence on acetaldehyde blood levels following ethanol ingestion: WT
No flushing, no hangover effects
61
ALDH2 influence on acetaldehyde blood levels following ethanol ingestion: Heterozygous
Some flushing, some hangover effects
62
ALDH2 influence on acetaldehyde blood levels following ethanol ingestion: Homozygous variant
Flushing, hangover effects (not converting acetaldehyde toxic metabolite into acetic acid)
63
What is disulfiram?
- Drug used to treat chronic alcoholism - Inhibits aldehyde dehydrogenase resulting in acetaldehyde accumulation
64
Estrogen receptor-positive breast cancer is under the control of ____ and can be effectively treated with ____
Estrogen; anti-estrogens
65
Anti-estrogens work by:
Binding to estrogen receptors, blocking estrogen from binding, stopping cell proliferation
66
____ is an anti-estrogen
Tamoxifen
67
CYP2D6 biotransforms tamoxifen into:
Endoxifen (potent antiestrogen)
68
CYP2D6 genotypes have been associated with ____ of endoxifen
Variability in plasma concentrations
69
PM phenotype results in ____ endoxifen plasma concentrations in tamoxifen-treated breast cancer patients
Reduced
70
EM phenotype results in ____ serum concentrations of endoxifen
Significantly higher
71
PM phenotype serves as:
A predictor of breast cancer outcome in postmenopausal women taking tamoxifen for breast cancer (shorter time to cancer recurrence, worse relapse-free survival)
72
True or false: Dentists will be accountable for prescribing drugs appropriately to genetic subgroups
True

DEN 7203 Pharmacological Concepts (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions